GUANFACINE HCL ER 4 MG TABLET
For 30 tablets
Pharmacies pay
$5.29 filed
30 × $0.17621 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$25.20 filed
30 × $0.83991 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
4.8× estimated
Medicare paid 4.8× what pharmacies pay.
Part D averages every strength and form sold under “Guanfacine HCl ER” / “Guanfacine HCl” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$11.08 estimated
$5.29 + $0.79 (15%) + $5.00 fee per fill = $11.08
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
GUANFACINE HCL ER 4 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as guanfacine, under the trade name “Guanfacine Extended-Release”.
FDA gives its dosage form as tablet, extended release and its route as oral.
FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Actavis Pharma, Inc., Upsher-Smith Laboratories, LLC and Unichem Pharmaceuticals (USA), Inc.
FDA’s Established Pharmacologic Class for it is Central alpha-2 Adrenergic Agonist.
The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $5.29 for 30 tablets (30 × $0.17621 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 8 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Actavis Pharma, Inc. | 1 | $0.17621 per EA filed |
| Advagen Pharma Limited | 1 | $0.17621 per EA filed |
| Alembic Pharmaceuticals Inc. | 1 | $0.17621 per EA filed |
| Apotex Corp. | 1 | $0.17621 per EA filed |
| Fosun Pharma USA, Inc | 1 | $0.17621 per EA filed |
| Slate Run Pharmaceuticals, LLC | 1 | $0.17621 per EA filed |
| Unichem Pharmaceuticals (USA), Inc. | 1 | $0.17621 per EA filed |
| Upsher-Smith Laboratories, LLC | 1 | $0.17621 per EA filed |
All 8 NDCs, with labeler and price
- 00228-2855-11 · Actavis Pharma, Inc. · $0.17621 per EA · eff. 2026-09-23 filed
- 24979-0538-01 · Upsher-Smith Laboratories, LLC · $0.17621 per EA · eff. 2026-09-23 filed
- 29300-0463-01 · Unichem Pharmaceuticals (USA), Inc. · $0.17621 per EA · eff. 2026-09-23 filed
- 60505-3930-01 · Apotex Corp. · $0.17621 per EA · eff. 2026-09-23 filed
- 62332-0748-31 · Alembic Pharmaceuticals Inc. · $0.17621 per EA · eff. 2026-09-23 filed
- 70436-0042-01 · Slate Run Pharmaceuticals, LLC · $0.17621 per EA · eff. 2026-09-23 filed
- 72266-0258-55 · Fosun Pharma USA, Inc · $0.17621 per EA · eff. 2026-09-23 filed
- 72888-0227-01 · Advagen Pharma Limited · $0.17621 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
9 other products in the NADAC file share the FDA nonproprietary name guanfacine with GUANFACINE HCL ER 4 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| GUANFACINE 1 MG TABLET | $0.14657 per EA filed | $0.56698 per EA filed |
| GUANFACINE 2 MG TABLET | $0.26727 per EA filed | $0.56698 per EA filed |
| GUANFACINE HCL ER 1 MG TABLET | $0.13256 per EA filed | $0.83991 per EA filed |
| GUANFACINE HCL ER 2 MG TABLET | $0.14767 per EA filed | $0.83991 per EA filed |
| GUANFACINE HCL ER 3 MG TABLET | $0.16584 per EA filed | $0.83991 per EA filed |
| GUANFACINE HCL ER 4 MG TABLET this page | $0.17621 per EA filed | $0.83991 per EA filed |
| INTUNIV ER 1 MG TABLET | $9.38648 per EA filed | We don’t know yet |
| INTUNIV ER 2 MG TABLET | $9.26199 per EA filed | We don’t know yet |
| INTUNIV ER 3 MG TABLET | $9.29231 per EA filed | We don’t know yet |
| INTUNIV ER 4 MG TABLET | $9.26984 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 8 NDCs’ NADAC prices is $0.17621 per EA filed.
Of the 22 other products in FDA’s Central alpha-2 Adrenergic Agonist class priced per EA, 10 have a higher middle NADAC price and 12 a lower one. The one in the middle is GUANFACINE HCL ER 2 MG TABLET, at $0.14767 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $25.20 for 30 tablets, at an average of $0.83991 per EA in 2024 (2024-01-01 to 2024-12-31) for “Guanfacine HCl ER” and “Guanfacine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 134,577 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for GUANFACINE HCL ER 4 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Guanfacine HCl ER / Guanfacine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- TIZANIDINE HCL 2 MG CAPSULE
- TIZANIDINE HCL 2 MG TABLET
- CLONIDINE HCL ER 0.1 MG TABLET
- CLONIDINE HCL ER 0.17 MG TAB
- JAVADIN 0.02 MG/ML SOLUTION